Ivonescimab +mFOLFOXIRI +celecoxib Clinical Trials

1 actively recruiting trial

Also known as: 5-Fluorouracil, Irinotecan, Ivonescimab, Leucovorin, Oxaliplatin +1 more

Pipeline

Phase 2: 1

Top Sponsors

Sun Yat-sen University1

Indications

Colorectal Cancer1
Cancer1

Other1 trial

Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.